Lothian Partners

Total investments

8

Average round size

21M

Portfolio companies

6

Follow on index

0.25

Exits

1

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareGeneticsManufacturingMedicalPharmaceuticalTherapeuticsTelecommunicationsEnergy

Summary

The leading representative office of defined Corporate Investor is situated in the London. The venture was found in Europe in United Kingdom.

Among the most popular fund investment industries, there are Software, Robotics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Enobia Pharma, Simpler Networks, Microbridge Technologies Canada For fund there is no match between the location of its establishment and the land of its numerous investments - Canada.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Lothian Partners, startups are often financed by Fonds de solidaritu00e9 FTQ, Desjardins Venture Capital, Kodiak Venture Partners. The meaningful sponsors for the fund in investment in the same round are Fonds de solidaritu00e9 FTQ, Desjardins Venture Capital, OrbiMed. In the next rounds fund is usually obtained by Aster, OrbiMed, Kodiak Venture Partners.

The top activity for fund was in 2005. Opposing the other organizations, this Lothian Partners works on 16 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2011.

Show more

Investments analytics

Analytics

Total investments
8
Lead investments
0
Exits
1
Follow on index
0.25
Investments by industry
  • Biotechnology (4)
  • Medical (3)
  • Health Care (3)
  • Manufacturing (3)
  • Software (3)
  • Show 8 more
Investments by region
  • Canada (8)
Peak activity year
2005

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Group Appearance index
1.00
Avg. company exit year
14

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
BioAxone Therapeutic 20 May 2005 Biotechnology, Health Care, Therapeutics Early Stage Venture 12M Manitoba, Canada, Canada

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.